The Efficacy of Guided Tissue Regeneration With Extracellular Matrix Scaffold of Small Intestinal Submucosa (SIS) Membrane: a Randomized Controlled Clinical Trial
Peking University School of Stomatology
1 other identifier
interventional
20
1 country
1
Brief Summary
The most commonly used barrier membrane material in guided tissue regeneration is absorbable collagen membrane. Although the collagen membrane has a good barrier effect, it lacks the growth factors needed for periodontal tissue regeneration, which affects the effect of collagen membrane on periodontal tissue regeneration. Extracellular Matrix Scaffold of Small Intestinal Submucosa (SIS) Membrane is a novel absorbable membrane that retains the extracellular matrix structure and is conducive to vascular ingrowth and tissue repair. The in vitro study showed that SIS membrane had excellent biocompatibility and certain antibacterial effect. Preclinical study also showed that SIS membrane significantly promoted the differentiation of bone marrow mesenchymal stem cells into osteoblasts, and promoted bone regeneration more effectively than collagen mechanism materials. SIS membrane can be used in soft tissue wound repair, guided bone regeneration, site preservation and other surgeries, and has achieved good therapeutic effects. However, whether the application of SIS membrane can achieve good therapeutic effect on periodontal guide tissue regeneration is still unclear. Therefore, in this study, the effects of guide tissue regeneration with collagen membrane and SIS membrane were compared through a randomized controlled clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2023
CompletedStudy Start
First participant enrolled
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
March 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMay 10, 2024
May 1, 2024
1.2 years
March 1, 2023
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
clinical attachment loss
before and 6 months after surgery, examine the changes of CAL
Baseline and 6 months after surgery
clinical attachment loss
before and 12 months after surgery, examine the changes of CAL
baseline and 12 months after surgery.
Study Arms (2)
Small Intestinal Submucosa Membrane
EXPERIMENTALBio-guide
ACTIVE COMPARATORInterventions
after flap elevation and debridement, intrabony defect was filled with Bio-Oss and covered with membrane.
Eligibility Criteria
You may qualify if:
- periodontitis patients with stage III to IV, grade C had one or more intrabony defects with a depth of ≥3 mm; PD≥5mm after initial periodontal therapy.
You may not qualify if:
- smokers, pregnant female, other systematic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Hospital of stomatology
Beijing, Beijing Municipality, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2023
First Posted
March 29, 2023
Study Start
March 28, 2023
Primary Completion
June 1, 2024
Study Completion
January 1, 2025
Last Updated
May 10, 2024
Record last verified: 2024-05